Diagnosing and Treating Giant Cell Arteritis with Visual and Neurologic Impairments Webinar
Media formats available:
Details
Presenters
Overview
Supported through an educational grant from Genentech. Learning Objectives
Upon completion of this activity, the participant should be able to: • Recall patient risk factors and the range of symptoms of Giant Cell Arteritis, based on relevant classification and diagnostic criteria to confidently add GCA as a differential diagnosis. • Distinguish the visual abnormalities and ischemic events associated with Giant Cell Arteritis versus other causes. • Formulate treatment options for patients with recently diagnosed Giant Cell Arteritis, including GC-sparing regimens, second-line therapy. • Evaluate treatment options for patients with relapsing Giant Cell Arteritis, glucocorticoid-resistant GCA, and necessity of long term management. • Outline the underlying inflammatory processes involved in GCA and the evidence for targeted FDA approved therapy and emerging therapies for the treatment of GCA, including their use as second-line therapy. Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
Leonard H. Calabrese, DO Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Vice Chairman, Department of Rheumatic and Immunological Diseases R. J. Fasenmyer Chair of Clinical Immunology Cleveland Clinic Cleveland, Ohio Michael S. Lee, MD Professor, Department of Neurosurgery Professor, Department of Ophthalmology and Visual Neurosciences Professor, Department of Neurology Mackall-Scheie Research Chair, Department of Ophthalmology and Visual Neurosciences University of Minnesota Medical School Minneapolis, Minnesota The following faculty/staff members have the following financial relationships with commercial interests: Leonard Calabrese, DO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Abbvie; Bristol Myers Squibb; Crescendo Bioscience; Genentech; Jansen; and Regeneron Pharmaceuticals. Michael S. Lee, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Quark Pharmaceuticals.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Genentech. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!